# Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)

> **NCT00306891** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 60 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Cediranib
- **DRUG:** Cediranib 30 - 90 mg

## Key facts

- **NCT ID:** NCT00306891
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-01
- **Final completion:** 2008-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2012-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00306891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00306891, "Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00306891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*